Finally, we note reduced IRF1 mRNA expression in tumors from stage 3 and 4 colorectal cancer (Fig. 6C) that is associated with poorer prognosis and reduced survival times for these patients (Fig. 6D). This evidence concerns the gene IRF1 and colorectal cancer.